Price
$8.25
Decreased by -1.20%
Dollar volume (20D)
6.28 M
ADR%
4.51
Shares float
43.99 M
Shares short
3.06 M [6.96%]
Shares outstanding
50.04 M
Market cap
417.84 M
Beta
N/A
Price/earnings
N/A
20D range
7.54 10.44
50D range
7.54 11.74
200D range
7.12 14.22

Enhabit, Inc. provides home health and hospice services in the United States.

Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families.

The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022.

Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 7, 24 0.00
Decreased by -100.00%
0.04
Decreased by -100.00%
Mar 6, 24 0.06
Decreased by -81.25%
0.03
Increased by +100.00%
Nov 7, 23 0.03
Decreased by -84.21%
0.06
Decreased by -50.00%
Aug 9, 23 0.04
Decreased by -91.49%
0.14
Decreased by -71.43%
May 9, 23 0.09
Decreased by -84.24%
0.15
Decreased by -40.00%
Feb 14, 23 0.32 0.23
Increased by +39.13%
Nov 1, 22 0.19 0.28
Decreased by -32.14%
Aug 1, 22 0.47 0.49
Decreased by -4.08%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 23 260.60 M
Decreased by -5.27%
-6.40 M
Decreased by -183.12%
Decreased by -2.46%
Decreased by -187.74%
Sep 30, 23 258.30 M
Decreased by -2.79%
-2.40 M
Decreased by -127.91%
Decreased by -0.93%
Decreased by -128.71%
Jun 30, 23 262.30 M
Decreased by -2.13%
-74.40 M
Decreased by -470.15%
Decreased by -28.36%
Decreased by -478.19%
Mar 31, 23 265.10 M
Decreased by -3.35%
2.70 M
Decreased by -89.66%
Increased by +1.02%
Decreased by -89.30%
Dec 31, 22 275.10 M
Decreased by -0.36%
7.70 M
Decreased by -73.72%
Increased by +2.80%
Decreased by -73.62%
Sep 30, 22 265.70 M
Decreased by -2.99%
8.60 M
Decreased by -60.19%
Increased by +3.24%
Decreased by -58.96%
Jun 30, 22 268.00 M
Decreased by -6.33%
20.10 M
Decreased by -37.77%
Increased by +7.50%
Decreased by -33.57%
Mar 31, 22 274.30 M
Increased by +1.40%
26.10 M
Decreased by -6.45%
Increased by +9.52%
Decreased by -7.75%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY